Journal of the Korean Pediatric Society 1993;36(12):1701-1706.
Published online December 15, 1993.
The Effect of Prolonged Treatment in Children with Chronic Hepatitis B with Combination of Alpha-Interferon and Acyclovir
Jeong Ok Hah, Kyoung A Lee
Department of Pediatrics, College of Medicine, Yeungnam University, Taegu, Korea
소아 만성 B형 간염에 장기적인 Interferon-Alpha와 Acyclovir 병용치료 효과
하정옥, 이경아
영남대학교 의과대학 소아과학교실
This study was conducted to evaluate the effect of prolonged treatment in children with chronic hepatitis B will combination of alpha-interferon and acyclovir. The study population consisited of & patients with chronic hepatitis B who showed histological findings compatible with chronic active hepatitis (4 cases) or chronic persistent hepatitis (3 cases) on liver biopsy and had elevated AST and ALT with positive HBaAg, HBeAg and HBV-DNA for more than 6 months. Recombinant interferon-alpha-2 was given in a dose of 3 million IU/m2 daily for 3months with acyclovir in a dose of 15mg/kg of body weight every 12 hours for 7 days of each month for 3 months. Then, the same dose of interferon was given thrice a week for 9 more months. One patient who had vertically transmitted hepatitis B from her mother had received only 6 months of treatment in total as she did not show any effect after 6 months of treatment. Among 6 patients who had positive HBV-DNA on entry to the study, 4 patients (66.7%) showed conversion of HBV-DNA to negative. HBeAg was converted to negative in 3 patients (42.9%). AST and ALT became normal in 6 cases HHsAg remained positive in all cases. Prolonged treatment in children with chronic hepatitis B with combination of alpha interferon and acyclovir seems to be beneficial but the proper dosage and duration of therapy need to be determined with further and controlled study.
Key Words: Chronic Active Hepatitis B, Alpha-Interferon, Acyclovir, Children

METRICS Graph View
  • 1,656 View
  • 1 Download

Close layer
prev next